Skip to main content
Clinical Trials/RBR-3rx9fj
RBR-3rx9fj
Active, not recruiting
未知

A prospective cross-sectional and longitudinal study with additional restrospective chart review to evaluate clinical and biochemical characteristics and disease progression in patients with mucopolysaccharidosis type IIIB

Hospital de Clínicas de Porto Alegre0 sitesJuly 6, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Mucopolysaccharidosis type IIIB
Sponsor
Hospital de Clínicas de Porto Alegre
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 6, 2015
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
Hospital de Clínicas de Porto Alegre

Eligibility Criteria

Inclusion Criteria

  • Definitive diagnosis of MPS IIIB; at least 1 years of age (biological age) at the time of written informed consent; understands the full nature and purpose of the study, including possible risks of study procedures; informed consent signature.

Exclusion Criteria

  • Visual or hearing impairments sufficient to preclude cooperation with neurodevelopmental testing; history of poorly\-controlled seizure disorder; currently receiving medication which, in the Investigator’s opinion, would be likely to substantially confound interpretation of the results, or has been on the current dose of psychotropic medication for less than 3 months; receiving a newly increased dose of melatonin (e.g., less than 3 months on current dose); previously received an investigational therapy for the treatment of MPS IIIB or has had hematopoietic stem cell transplant (HSCT); in the opinion of the Investigator, the patient has any other prior or ongoing medical condition that may present a safety risk, interfere with study compliance, or confound data interpretation.

Outcomes

Primary Outcomes

Not specified

Similar Trials